Antipsychotic drug treatment in first-episode mania: A 6-month longitudinal study

Journal of Clinical Psychiatry

Volumn 61, Issue 1, 2000, Pages 33-38

  Zarate Jr , Carlos A ^a,c   Tohen, Mauricio ^a,b,d  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^d ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOZAPINE; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MANIA; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0343314921     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v61n0109     Document Type: Article

References (23)

1. Tohen M, Waternaux CM, Tsuang MT. Outcome in mania: a 4-year prospective follow-up of 75 patients utilizing survival analysis. Arch Gen Psychiatry 1990;47:1106-1111
2. Licht RW, Gouliaev G, Vestergaard P, et al. Treatment of manic episodes in Scandinavia: the use of neuroleptic drugs in a clinical routine setting. J Affect Disord 1994;32:179-185
3. Calabrese JR, Bowden C, Woyshville MJ. Lithium and the anticonvulsants in the treatment of bipolar disorder. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1994
4. Sernyak MJ, Griffin RA, Johnson RM, et al. Neuroleptic exposure following inpatient treatment of acute mania with lithium and neuroleptic. Am J Psychiatry 1994;151:133-135
5. Tohen M, Zarate CA Jr. Antipsychotic agents and bipolar disorder. J Clin Psychiatry 1998;59(suppl 1):38-48
6. Chou JC, Zito JM, Vitrai J, et al. Neuroleptics in acute mania: a pharmaco-epidemiologic study. Ann Pharmacother 1996;30:1396-1398
7. Verdoux H, Gonzales B, Takei N, et al. Survey of prescribing practice of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996;38:81-87
8. Keck PE Jr, McElroy SL, Strakowski SM, et al. Factors associated with maintenance antipsychotic treatment of patients with bipolar disorder. J Clin Psychiatry 1996;57:147-151
9. Kane JM. The role of neuroleptics in manic-depressive illness. J Clin Psychiatry 1988;49(11, suppl):12-13
10. American Psychiatric Association. Practice Guideline for the Treatment of Patients With Bipolar Disorder. Am J Psychiatry 1994;151:1-36
11. Spitzer RL, Williams JBW, Gibbon M, et al. Structured Clinical Interview for DSM-III-R, Patient Version (SCID-P). New York, NY: Biometric Research, New York State Psychiatric Institute; 1988
12. Lukoff D, Neuchterlein KH, Ventura J. Manual for the expanded Brief Psychiatric Rating Scale. Schizophr Bull 1986;12:594-602
13. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994:32
14. Tohen M, Stoll AL, Strakowski SM, et al. The McLean First-Episode Psychosis Project: six-month recovery and recurrence outcome. Schizophr Bull 1992;18:273-282
15. Keller MB, Lavori PW, Friedman B, et al. The Longitudinal Interval Follow-up Evaluation. Arch Gen Psychiatry 1987;44:540-548
16. Baldessarini RJ, Katz B, Cotton P. Dissimilar dosing with high-potency and low-potency neuroleptics. Am J Psychiatry 1984;141:748-752
17. Revicki DA, Tohen M, Gyulai L, et al. Telephone versus in-person clinical and health status assessment interviews in patients with bipolar disorder. Harvard Rev Psychiatry 1997;5:75-81
18. Nasrallah HA, Churchill CM, Hamdan-Allan GA. Higher frequency of neuroleptic-induced dystonia in mania than in schizophrenia. Am J Psychiatry 1998;145:1455-1456
19. Garfinkle PE, Stancer HG, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord 1980;2:279-288
20. Baldessarini RJ, Kando JC, Centorrino F. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay. Am J Psychiatry 1995;152:1038-1044
21. Sernyak MJ, Woods SW. Chronic neuroleptic use in manic-depressive illness. 1993;29:375-379
22. Verdoux H, Gonzales B, Takei N, et al. Survey of prescribing practices of antipsychotic maintenance treatment for manic-depressive outpatients. J Affect Disord 1996;38:81-87
23. Cochran SD. Compliance with lithium regimens in the outpatient treatment of bipolar affective disorders. J Compliance Health Care 1986;1: 153-170